| Dr Joseph R Terracina, MD PA | |
|
2525 Highway 1 S, Suite A, Greenville, MS 38701-8354 | |
| (662) 335-1103 | |
| (662) 335-8746 |
| Full Name | Dr Joseph R Terracina |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 35 Years |
| Location | 2525 Highway 1 S, Greenville, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316909724 | NPI | - | NPPES |
| 1981966 | Other | MS | LOUISIANA MEDICAID NUMBER |
| 0111878 | Medicaid | MS | |
| 123945001 | Other | AR | MEDICAID PROVIDER NUMBER |
| 96649 | Other | AR | AR BCBS PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 12546 (Mississippi) | Primary |
| Entity Name | Dr Joseph R Terracina, Md, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134393952 PECOS PAC ID: 5294806618 Enrollment ID: O20080612000360 |
News Archive
Around 15% of ovarian cancer cases are linked to genetic mutations such as BRCA1, BRCA2 and Lynch Syndrome, which increase an individual's likelihood of developing ovarian and other cancers. This equates to over 1,000 women a year in the UK whose lives could potentially be saved.
Five percent of cancer patients and their families were pushed into poverty in Southeast Asia between March 2012 and September 2013, because of high disease-related costs, a study at the inaugural ESMO Asia 2015 Congress in Singapore shows.
CLEAR, the powerful public and proprietary records service and investigative suite from Thomson Reuters, is well-regarded among law enforcement and government investigative professionals for helping nab criminals and recover missing children. Today, the business is introducing a new version of the service to aid in the recovery of the $60 billion that the National Health Care Anti-Fraud Association estimates is lost each year to fraud.
The University of Michigan Health System doesn't claim to be perfect. But its response to medical errors, near-misses, unexpected clinical problems and unintended outcomes is a model for the nation that other hospitals can and should copy, according to a new paper in a prestigious health care journal.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has entered into an exclusive, world-wide product development and distribution agreement with DiaSorin S.p.A. Under terms of the agreement, DiaSorin will utilize key Meridian technology to develop several infectious disease products for use on their LIAISON systems.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph R Terracina, MD PA 2525 Highway 1 S Ste A, Greenville, MS 38701-8354 Ph: (662) 335-1103 | Dr Joseph R Terracina, MD PA 2525 Highway 1 S, Suite A, Greenville, MS 38701-8354 Ph: (662) 335-1103 |
News Archive
Around 15% of ovarian cancer cases are linked to genetic mutations such as BRCA1, BRCA2 and Lynch Syndrome, which increase an individual's likelihood of developing ovarian and other cancers. This equates to over 1,000 women a year in the UK whose lives could potentially be saved.
Five percent of cancer patients and their families were pushed into poverty in Southeast Asia between March 2012 and September 2013, because of high disease-related costs, a study at the inaugural ESMO Asia 2015 Congress in Singapore shows.
CLEAR, the powerful public and proprietary records service and investigative suite from Thomson Reuters, is well-regarded among law enforcement and government investigative professionals for helping nab criminals and recover missing children. Today, the business is introducing a new version of the service to aid in the recovery of the $60 billion that the National Health Care Anti-Fraud Association estimates is lost each year to fraud.
The University of Michigan Health System doesn't claim to be perfect. But its response to medical errors, near-misses, unexpected clinical problems and unintended outcomes is a model for the nation that other hospitals can and should copy, according to a new paper in a prestigious health care journal.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has entered into an exclusive, world-wide product development and distribution agreement with DiaSorin S.p.A. Under terms of the agreement, DiaSorin will utilize key Meridian technology to develop several infectious disease products for use on their LIAISON systems.
› Verified 9 days ago